Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound_老虎社区_美港股上老虎

Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound

CNBC2021-08-27

It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings. Shares of Wood’s ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

238

Eskay_Tew
·2021-08-31
Looks good.. I have in my portfolio
回复
点赞
举报
hpt
·2021-08-29
Nice
回复
1
举报
replaygoh
·2021-08-29
thx...
回复
1
举报
收起
- Baby Step 4:
  ✌🏽
  2021-08-29
  回复
  举报
JoelLee
·2021-08-28
Reply and comment pls thx
回复
5
举报
收起
- Chanelyap:
  Ok
  2021-08-28
  回复
  举报
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-08-29
  回复
  举报
STKG
·2021-08-28
Still Wood?? Touch wood our investment can be better growth
回复
1
举报
收起
- tig2021:
  haha
  2021-08-28
  回复
  举报
jayfalcon
·2021-08-28
Thanks for sharing
回复
1
举报
seojun
·2021-08-28
I trust u....
回复
3
举报
ToongMH
·2021-08-28
Good to read
回复
3
举报
7a496f67
·2021-08-28
Ok
回复
1
举报
replaygoh
·2021-08-28
noted
回复
2
举报
Fayna
·2021-08-28
Hopefully will be like last year
回复
3
举报
收起
- EmChung:
  Yes
  2021-08-28
  回复
  举报
KLCC
·2021-08-27
Liked!
回复
2
举报
HENRYCSC
·2021-08-27
[Smile]
回复
2
举报
dt1
·2021-08-27
[微笑]
回复
1
举报
AxelOng
·2021-08-27
Sis Wood all the way
回复
4
举报
收起
- dt1:
  [微笑]
  2021-08-27
  回复
  举报
- seojun:
  yessss
  2021-08-28
  回复
  举报
Dena
·2021-08-27
☺️
回复
4
举报
potatochip
·2021-08-27
Go Cathie! [Bless] [Victory]
回复
9
举报
收起
- CL777:
  Ok
  2021-09-03
  回复
  举报
- CL777回复potatochip:
  Gd
  2021-09-02
  回复
  举报
- potatochip:
  [Cool]
  2021-08-28
  回复
  举报
查看更多 1 条评论
Eskay_Tew
·2021-08-27
Pretty hope it is true
回复
8
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1131568820?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-27 15:26","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1131568820","market":"us","top_or_hot":-1,"title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","media":"CNBC","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">网页链接</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWOU","symbol_name":"2U Inc","start_time":0,"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","article_id":"1131568820","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","pubTimestamp":1630049174,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWOU":"2U Inc","LC":"LendingClub","ARKF":"ARK Fintech Innovation ETF","SNAP":"Snap Inc","DDD":"3D系统","OPEN":"Opendoor Technologies Inc","ARKG":"ARK Genomic Revolution ETF","PDD":"拼多多","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","DE":"迪尔股份有限公司","ARKW":"ARK Next Generation Internation ETF","SKLZ":"Skillz Inc","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SURF":"Surface Oncology","NVDA":"英伟达","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","Z":"Zillow","CGEN":"Compugen医疗","INTU":"财捷","IOVA":"Iovance Biotherapeutics, Inc.","SE":"Sea Ltd","NET":"Cloudflare, Inc.","NIU":"小牛电动"},"translate_title":"以下是凯茜·伍德的股票表现如何，以及哪些股票有望在年底反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NIU":0.9,"Z":0.9,"TWOU":0.9,"SURF":0.9,"SNAP":0.9,"SKLZ":0.9,"SI":0.9,"SE":0.9,"REGN":0.9,"PRLB":0.9,"PDD":0.9,"OPEN":0.9,"ONEM":0.9,"NVDA":0.9,"NTLA":0.9,"ARKF":0.9,"NET":0.9,"LC":0.9,"IOVA":0.9,"INTU":0.9,"DE":0.9,"DDD":0.9,"CGEN":0.9,"BLI":0.9,"BILL":0.9,"ARKW":0.9,"ARKQ":0.9,"ARKK":0.9,"ARKG":0.9},"content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":818377499,"gmtCreate":1630380401511,"gmtModify":1704959430986,"author":{"id":"3578561972068295","authorId":"3578561972068295","name":"Eskay_Tew","avatar":"https://static.tigerbbs.com/c955d556458f3e647eb3cbf75c2f8f54","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Looks good.. I have in my portfolio&nbsp;","listText":"Looks good.. I have in my portfolio&nbsp;","text":"Looks good.. I have in my portfolio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818377499","repostId":1131568820,"repostType":2,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":813294377,"gmtCreate":1630203502699,"gmtModify":1704956964382,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/813294377","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":813822233,"gmtCreate":1630188957822,"gmtModify":1704956742809,"author":{"id":"3582963095283492","authorId":"3582963095283492","name":"replaygoh","avatar":"https://static.tigerbbs.com/d47b21291424a3d55039334a8de5cdb9","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"thx...","listText":"thx...","text":"thx...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/813822233","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5680206,"gmtCreate":1630202706049,"gmtModify":1635136805675,"authorId":3585617155516823,"author":{"id":3585617155516823,"authorId":3585617155516823,"name":"Baby Step 4","avatar":"https://static.tigerbbs.com/8ee1c9c06b2929c88e9f5bb3a24cf2d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813822233,"type":1,"supId":0,"prevId":0,"content":"✌🏽","text":"✌🏽","html":"✌🏽"}],"langContent":"EN"},{"id":813909478,"gmtCreate":1630117457294,"gmtModify":1704956211926,"author":{"id":"3579882572140125","authorId":"3579882572140125","name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Reply and comment pls thx&nbsp;","listText":"Reply and comment pls thx&nbsp;","text":"Reply and comment pls thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/813909478","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5675147,"gmtCreate":1630132362453,"gmtModify":1635137220244,"authorId":3581317711527033,"author":{"id":3581317711527033,"authorId":3581317711527033,"name":"Chanelyap","avatar":"https://static.tigerbbs.com/ead5a4e57e2f9f018e7802a33c0a28f5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813909478,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5679364,"gmtCreate":1630198445793,"gmtModify":1635136879500,"authorId":3567307840510045,"author":{"id":3567307840510045,"authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813909478,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."}],"langContent":"EN"},{"id":813038440,"gmtCreate":1630112898280,"gmtModify":1704956098661,"author":{"id":"3586131488444401","authorId":"3586131488444401","name":"STKG","avatar":"https://static.tigerbbs.com/730c2482b43ac1909a601868b378a6e4","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Still Wood?? Touch wood our investment can be better growth","listText":"Still Wood?? Touch wood our investment can be better growth","text":"Still Wood?? Touch wood our investment can be better growth","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/813038440","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5677094,"gmtCreate":1630156986040,"gmtModify":1631894244521,"authorId":3587008457873110,"author":{"id":3587008457873110,"authorId":3587008457873110,"name":"tig2021","avatar":"https://static.tigerbbs.com/86558e2c1be0fae967630b306994ef5a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":813038440,"type":1,"supId":0,"prevId":0,"content":"<u>haha</u>","text":"<u>haha</u>","html":"<u>haha</u>"}],"langContent":"EN"},{"id":819760022,"gmtCreate":1630108489566,"gmtModify":1704955988056,"author":{"id":"4090418835913750","authorId":"4090418835913750","name":"jayfalcon","avatar":"https://static.tigerbbs.com/505029b8d840d52745c57c2cbf910d5c","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Thanks for sharing","listText":"Thanks for sharing","text":"Thanks for sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819760022","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819731617,"gmtCreate":1630106512439,"gmtModify":1704955948287,"author":{"id":"4087771643270940","authorId":"4087771643270940","name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"I trust u....","listText":"I trust u....","text":"I trust u....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819731617","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819790596,"gmtCreate":1630105483315,"gmtModify":1704955927903,"author":{"id":"3579230468032082","authorId":"3579230468032082","name":"ToongMH","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good to read","listText":"Good to read","text":"Good to read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819790596","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819701937,"gmtCreate":1630104803129,"gmtModify":1704955917185,"author":{"id":"3582403544178531","authorId":"3582403544178531","name":"7a496f67","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819701937","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819440503,"gmtCreate":1630101472802,"gmtModify":1704955883466,"author":{"id":"3582963095283492","authorId":"3582963095283492","name":"replaygoh","avatar":"https://static.tigerbbs.com/d47b21291424a3d55039334a8de5cdb9","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"noted","listText":"noted","text":"noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819440503","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819571279,"gmtCreate":1630080968391,"gmtModify":1704955756985,"author":{"id":"3576151042223854","authorId":"3576151042223854","name":"Fayna","avatar":"https://static.tigerbbs.com/d82d63e2a39fe69931574815c44edce8","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Hopefully will be like last year&nbsp;","listText":"Hopefully will be like last year&nbsp;","text":"Hopefully will be like last year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/819571279","repostId":1131568820,"repostType":2,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5669698,"gmtCreate":1630083157408,"gmtModify":1635137684327,"authorId":3566723689439669,"author":{"id":3566723689439669,"authorId":3566723689439669,"name":"EmChung","avatar":"https://static.tigerbbs.com/99db9b9b2d5d303db43970c31a6ba528","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819571279,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":819535082,"gmtCreate":1630076471146,"gmtModify":1704955658192,"author":{"id":"3582008315299880","authorId":"3582008315299880","name":"KLCC","avatar":"https://static.tigerbbs.com/08be1d09de6993c135144551b2568831","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Liked!","listText":"Liked!","text":"Liked!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819535082","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819532305,"gmtCreate":1630076417607,"gmtModify":1704955656473,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819532305","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819590464,"gmtCreate":1630075525158,"gmtModify":1704955633391,"author":{"id":"3577530901336464","authorId":"3577530901336464","name":"dt1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819590464","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":819502550,"gmtCreate":1630075318070,"gmtModify":1704955627835,"author":{"id":"4089463306606890","authorId":"4089463306606890","name":"AxelOng","avatar":"https://static.tigerbbs.com/8eaa7b50259b0329b74e09bc501ecd38","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Sis&nbsp;Wood all the way&nbsp;","listText":"Sis&nbsp;Wood all the way&nbsp;","text":"Sis Wood all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/819502550","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5668514,"gmtCreate":1630075541817,"gmtModify":1635137758951,"authorId":3577530901336464,"author":{"id":3577530901336464,"authorId":3577530901336464,"name":"dt1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819502550,"type":1,"supId":0,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]"},{"id":5670917,"gmtCreate":1630106526191,"gmtModify":1635137591388,"authorId":4087771643270940,"author":{"id":4087771643270940,"authorId":4087771643270940,"name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819502550,"type":1,"supId":5668514,"prevId":0,"content":"yessss","text":"yessss","html":"yessss"}],"langContent":"EN"},{"id":819506487,"gmtCreate":1630075244249,"gmtModify":1704955626632,"author":{"id":"3582631807559872","authorId":"3582631807559872","name":"Dena","avatar":"https://static.tigerbbs.com/b4df51b924cc0c8a69b75cd36c01445d","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"☺️","listText":"☺️","text":"☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819506487","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":819275266,"gmtCreate":1630074843555,"gmtModify":1704955616467,"author":{"id":"3570923041276809","authorId":"3570923041276809","name":"potatochip","avatar":"https://static.tigerbbs.com/279b09d8c5dbf0fd92a959709ef9b5ff","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Go Cathie! [Bless]&nbsp;[Victory]&nbsp;","listText":"Go Cathie! [Bless]&nbsp;[Victory]&nbsp;","text":"Go Cathie! [Bless] [Victory]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/819275266","repostId":1131568820,"repostType":4,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5736223,"gmtCreate":1630629416342,"gmtModify":1631890265393,"authorId":3560241002253187,"author":{"id":3560241002253187,"authorId":3560241002253187,"name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819275266,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5723711,"gmtCreate":1630541475693,"gmtModify":1631890265379,"authorId":3560241002253187,"author":{"id":3560241002253187,"authorId":3560241002253187,"name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3570923041276809,"repliedAuthor":{"id":3570923041276809,"authorId":3570923041276809,"name":"potatochip","avatar":"https://static.tigerbbs.com/279b09d8c5dbf0fd92a959709ef9b5ff","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":819275266,"type":1,"supId":5671541,"prevId":5674761,"content":"Gd","text":"Gd","html":"Gd"},{"id":5674761,"gmtCreate":1630128441965,"gmtModify":1631890265366,"authorId":3570923041276809,"author":{"id":3570923041276809,"authorId":3570923041276809,"name":"potatochip","avatar":"https://static.tigerbbs.com/279b09d8c5dbf0fd92a959709ef9b5ff","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819275266,"type":1,"supId":5671541,"prevId":0,"content":"[Cool]","text":"[Cool]","html":"[Cool]"},{"id":5671541,"gmtCreate":1630110225967,"gmtModify":1631890265257,"authorId":3560241002253187,"author":{"id":3560241002253187,"authorId":3560241002253187,"name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":819275266,"type":1,"supId":0,"prevId":0,"content":"Yeah","text":"Yeah","html":"Yeah"}],"langContent":"EN"},{"id":819810131,"gmtCreate":1630053420723,"gmtModify":1704955226925,"author":{"id":"3578561972068295","authorId":"3578561972068295","name":"Eskay_Tew","avatar":"https://static.tigerbbs.com/c955d556458f3e647eb3cbf75c2f8f54","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pretty hope it is true&nbsp;","listText":"Pretty hope it is true&nbsp;","text":"Pretty hope it is true","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819810131","repostId":1131568820,"repostType":2,"repost":{"id":"1131568820","pubTimestamp":1630049174,"share":"https://www.laohu8.com/m/news/1131568820?lang=&edition=full","pubTime":"2021-08-27 15:26","market":"us","language":"en","title":"Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1131568820","media":"CNBC","summary":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall","content":"<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Cathie Wood’s stocks are doing and which ones are candidates for a late-year rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","NVDA":"英伟达","INTU":"财捷","CGEN":"Compugen医疗","ARKG":"ARK Genomic Revolution ETF","IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","SKLZ":"Skillz Inc","NIU":"小牛电动","ARKW":"ARK Next Generation Internation ETF","TWOU":"2U Inc","LC":"LendingClub","NET":"Cloudflare, Inc.","PDD":"拼多多","OPEN":"Opendoor Technologies Inc","REGN":"再生元制药公司","PRLB":"Proto Labs Inc","DDD":"3D系统","SURF":"Surface Oncology","ONEM":"1Life Healthcare, Inc.","NTLA":"Intellia Therapeutics Inc","BILL":"BILL HOLDINGS INC","SE":"Sea Ltd","DE":"迪尔股份有限公司","Z":"Zillow","SNAP":"Snap Inc"},"source_url":"https://www.cnbc.com/2021/08/26/arks-cathie-wood-holds-these-stocks-these-names-are-likely-to-bounce.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131568820","content_text":"It’s been a tumultuous year for closely watched fund manager Cathie Wood’s innovation ETFs, but Wall Street analysts see prospects improving for a bunch of her funds’ holdings.\nShares of Wood’s flagship Ark Innovation are down more than 3% this year after a rough first half of 2021 amid a rotation from growth stocks into value. Still, more than $6 billion flowed into Ark Innovation in 2021, according to FactSet. Wood made a name for herself after Ark Innovation returned nearly 150% in 2020.\n\nWood’s other funds are a mixed bag.Ark Next Generation Internet ETF is up 2% for 2021, and Ark Genomic Revolution ETF is down 10%.Ark Fintech Innovation ETF has gained 6% this year, and Ark Autonomous Technology & Robotics ETF has climbed more than 8% in that time period.\nDespite the funds’ relative underperformance to the major U.S. benchmarks, several names in the Ark funds have crushed it this year.\nTake a look at the best-performing stocks in Wood’s Ark funds so far in 2021.\n\nIntellia Therapeutics is the best-performing stock in Wood’s funds after returning more than 185% this year. In late June, the Massachusetts-based company and partner Regeneron announced positive results in a phase one study of a gene-editing treatment for a disease called transthyretin amyloidosis.\nLendingClub,Nvidia,Sea and Bill.com have also seen stellar performance this year.Deere,Intuit and Snap also make the list.\nCNBC Pro’s list did not include companies that went public in 2021; however, Ark owns several newly public companies. Self-driving truck company TuSimple is up roughly 20% since its debut in April, and Roblox shares have climbed since the gaming company’s IPO in March.\nCoinbase, the world’s largest cryptocurrency exchange, went public in April and opened at $381 per share. The stock is currently trading around $250 per share. Its price movements closely follow those of bitcoin.\nIn terms of the worst performers,Seres Therapeutics tops the list after declining nearly 75% in 2021.Berkeley Lights,Materialise,Pluristem Therapeutics and Proto Labs have also dragged down Wood’s funds.\nTake a look at the worst-performing stocks in Wood’s Ark funds so far in 2021.\n\nLooking ahead for Ark Invest\nIt’s important to note that some of the worst performers this year are the stocks that Wall Street expects will mount a comeback in the next 12 months.\nWhile Seres Therapeutics is the biggest laggard among Wood’s holdings, it’s also the top stock that analysts see outperforming in the next year. Nearly 80% of analysts covering the stock have buy ratings on the name, according to FactSet. On average, analysts see an upside of 230%.\nThe biotech company’s lead microbiome therapy is approaching a biologics license application filing in the third quarter of this year.\n“In Phase 3, SER-109 had clean safety data, along with 24-week data showing durable efficacy. Validating high interest in the program, Seres has an agreement with Nestle Health Science to jointly commercialize SER-109 worldwide,” Canaccord Genuity analyst John Newman told clients.\nLooking ahead, CNBC Pro screened for the Ark Invest-owned stocks that analysts think have the best chance of roaring back from their recent weakness.\nThe listed stocks are holdings in one of Ark’s core ETFs. Plus, Wall Street expects these names to rally more than 60% in the next year, based on the stocks’ average 12-month price target from analysts.\nLastly, the listed stocks have more than 50% of analysts assigning them a buy rating, with a minimum of five analysts covering the equity.\nTake a look at CNBC Pro’s list here:\n\nCompugen and Niu Technologies are two Ark Invest-held names that are universally loved on Wall Street. Both stocks have 100% of analysts rating them as a buy. Analysts expect Compugen to rally nearly 220% and Niu Technologies to gain more than 65% in the next 12 months.\nWhile Surface Oncology is down more than 35% this year, the company reported better-than-expected earnings earlier this month. The company is a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment and hit a milestone with its small-cell lung cancer treatment.\nAnalysts see Surface Oncology roaring back more than 150% in the next year.\nZillow is expected to gain more than 62% in the next 12 months. The online housing marketplace’s president told CNBC the company should benefit from increased home listings as Covid certainty improves.\nBerkeley Lights,1Life Healthcare,Personalis,Iovance Biotherapeutics and Skillz also made Wall Street’s list of favorite Ark stocks.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":238,"commentSize":18,"repostSize":0,"favoriteSize":5,"likeStatus":false,"favoriteStatus":false}}